Jens Ulrich

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · The Lancet Oncology · 2016 · 684 citations

Surgical Oncology, Medicine, Surgical Pathology +7

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Caroline Voskens, Simone M. Goldinger, Carmen Loquai et al. · PLoS ONE · 2013 · 463 citations · Full text

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Alexander Stratigos, Aleksandar Sekulić, Ketty Peris et al. · The Lancet Oncology · 2021 · 266 citations · Full text

Medicine, Hedgehog Inhibitor Therapy, Dermatology +5

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · Journal of Clinical Oncology · 2019 · 236 citations

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

Anne B. Bong, Bernd Bonnekoh, Ingolf Franke et al. · Dermatology · 2002 · 154 citations